Joseph P McEvoy

Joseph P McEvoy

UNVERIFIED PROFILE

Are you Joseph P McEvoy?   Register this Author

Register author
Joseph P McEvoy

Joseph P McEvoy

Publications by authors named "Joseph P McEvoy"

Are you Joseph P McEvoy?   Register this Author

98Publications

1887Reads

6Profile Views

Total and differential white blood cell counts, inflammatory markers, adipokines, and incident metabolic syndrome in phase 1 of the clinical antipsychotic trials of intervention effectiveness study.

Schizophr Res 2019 Jul 19;209:193-197. Epub 2019 May 19.

Department of Psychiatry and Health Behavior, Augusta University, Augusta, GA, United States. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.schres.2019.04.021DOI Listing
July 2019

Evidence-Based Strategies for Managing Tardive Dyskinesia.

Authors:
Joseph P McEvoy

J Clin Psychiatry 2018 Jan/Feb;79(1)

Medical College of Georgia, Augusta University, Augusta, Georgia, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4088/JCP.NU16048CC2CDOI Listing
June 2019

What You Should Know About Tardive Dyskinesia: Screening, Causes, and New Treatment Options.

J Clin Psychiatry 2018 Jan/Feb;79(1)

Department of Psychiatry and Health Behavior, Medical College of Georgia, Augusta University, Augusta, Georgia, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4088/JCP.NU16048WC3CDOI Listing
June 2019

Characterizing Treatment Effects of Valbenazine for Tardive Dyskinesia: Additional Results From the KINECT 3 Study.

J Clin Psychiatry 2018 12 18;80(1). Epub 2018 Dec 18.

Neurocrine Biosciences, Inc, San Diego, California, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4088/JCP.18m12278DOI Listing
December 2018

Heterogeneity of Treatment Effects of Long-Acting Injectable Antipsychotic Medications.

J Clin Psychiatry 2018 11 27;80(1). Epub 2018 Nov 27.

Department of Psychiatry and Health Behaviors, Augusta University Health, Augusta, Georgia, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4088/JCP.18m12109DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6296243PMC
November 2018

Inflammation, substance use, psychopathology, and cognition in phase 1 of the clinical antipsychotic trials of intervention effectiveness study.

Schizophr Res 2018 05 24;195:275-282. Epub 2017 Aug 24.

Department of Psychiatry and Health Behavior, Augusta University, Augusta, GA, United States.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.schres.2017.08.027DOI Listing
May 2018

Prioritizing Harm.

J Pers Assess 2017 Jan-Feb;99(1):78-82. Epub 2016 Jun 1.

a Department of Psychiatry and Health Behavior , Augusta University.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/00223891.2016.1180625DOI Listing
October 2017

The RAISE Connection Program: Psychopharmacological Treatment of People With a First Episode of Schizophrenia.

Psychiatr Serv 2016 12 1;67(12):1300-1306. Epub 2016 Jul 1.

Dr. Kreyenbuhl, Dr. Medoff, and Dr. Hackman are with the Department of Psychiatry, University of Maryland School of Medicine, Baltimore (e-mail: ). Dr. Kreyenbuhl and Dr. Medoff are also with the Mental Illness Research, Education and Clinical Center, Department of Veterans Affairs Capitol Healthcare Network (VISN 5), Baltimore. Dr. McEvoy is with the Department of Psychiatry, Medical College of Georgia, Augusta University, Augusta. Dr. Smith, Dr. Nossel, Dr. Dixon, and Dr. Essock are with the Department of Psychiatry, Columbia University College of Physicians and Surgeons, and with the New York State Psychiatric Institute, New York City. Dr. Buchanan is with the Maryland Psychiatric Research Center, Department of Psychiatry, University of Maryland School of Medicine, Baltimore.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1176/appi.ps.201500438DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5633208PMC
December 2016

Cost-Effectiveness of Long-Acting Injectable Paliperidone Palmitate Versus Haloperidol Decanoate in Maintenance Treatment of Schizophrenia.

Psychiatr Serv 2016 10 1;67(10):1124-1130. Epub 2016 Jun 1.

Dr. Rosenheck is with the Department of Psychiatry, Yale Medical School, New Haven, Connecticut, and with the U.S. Department of Veterans Affairs New England Mental Illness Research, Education and Clinical Center, West Haven (e-mail: ). Dr. Leslie is with the Department of Public Health Sciences and Psychiatry, Penn State University College of Medicine, Hershey, Pennsylvania. Mr. Sint, Dr. Lin, and Mr. Li are with the Yale School of Public Health, New Haven, Connecticut. Dr. McEvoy is with the Medical College of Georgia, Georgia Regents University, Augusta. Dr. Byerly is with the Department of Psychiatry, University of Texas Southwestern Medical Center, Dallas. Dr. Hamer, who is deceased, was with the Department of Psychiatry, University of North Carolina School of Medicine, Chapel Hill, at the time of this study. He was a beloved colleague, and we will miss his friendship, intelligence, and collegiality and will remember his special contributions to our field. Dr. Swartz is with the Department of Psychiatry, Duke University Medical Center, Durham, North Carolina. Dr. Stroup is with the Columbia University College of Physicians and Surgeons, New York.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5048499PMC
http://dx.doi.org/10.1176/appi.ps.201500447DOI Listing
October 2016

Use of Clozapine in Schizophrenia.

Authors:
Joseph P McEvoy

JAMA Psychiatry 2016 10;73(10):1097-1098

Department of Psychiatry and Health Behavior, Medical College of Georgia, Augusta.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jamapsychiatry.2016.1241DOI Listing
October 2016

Placebo controls in clinical trials: concerns about use in relapse prevention studies in schizophrenia.

BMJ 2016 Sep 9;354:i4728. Epub 2016 Sep 9.

State University of New York, Brooklyn, NY, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/bmj.i4728DOI Listing
September 2016

Placebo controls in clinical trials: concerns about use in relapse prevention studies in schizophrenia.

BMJ 2016 Sep 9;354:i4728. Epub 2016 Sep 9.

State University of New York, Brooklyn, NY, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/bmj.i4728DOI Listing
September 2016

Total and differential white blood cell counts, inflammatory markers, adipokines, and the metabolic syndrome in phase 1 of the clinical antipsychotic trials of intervention effectiveness study.

Schizophr Res 2015 Dec 21;169(1-3):30-35. Epub 2015 Oct 21.

Department of Psychiatry and Health Behavior, Augusta University, Augusta, GA, United States. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.schres.2015.10.001DOI Listing
December 2015

Adjunctive Minocycline in Clozapine-Treated Schizophrenia Patients With Persistent Symptoms.

J Clin Psychopharmacol 2015 Aug;35(4):374-81

From the *Maryland Psychiatric Research Center, University of Maryland School of Medicine, Baltimore, MD; †Department of Psychiatry, Georgia Regents University, Medical College of Georgia, Augusta, GA; ‡Department of Psychiatry, Clinical Research Program, Sheppard Pratt Health System and University of Maryland School of Medicine, Baltimore, MD; and §Department of Psychiatry, Psychology and Neuroscience, Duke University School of Medicine, Durham, NC.

View Article

Download full-text PDF

Source
http://pdfs.journals.lww.com/psychopharmacology/2015/08000/A
Web Search
http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:land
Publisher Site
http://dx.doi.org/10.1097/JCP.0000000000000345DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4485552PMC
August 2015

Antipsychotic medications for schizophrenia--reply.

JAMA 2014 Oct;312(14):1469

University of North Carolina, Chapel Hill.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jama.2014.10112DOI Listing
October 2014

Effectiveness of lurasidone in patients with schizophrenia or schizoaffective disorder switched from other antipsychotics: a randomized, 6-week, open-label study.

J Clin Psychiatry 2013 Feb;74(2):170-9

Department of Psychiatry and Behavioral Sciences, Duke University Medical Center, Durham, North Carolina, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4088/JCP.12m07992DOI Listing
February 2013

Optimizing outcome with antipsychotic treatment in first-episode schizophrenia: balancing efficacy and side effects.

Clin Schizophr Relat Psychoses 2012 Oct;6(3):115-21

Department of Psychiatry, Harvard Medical School, Massachusetts General Hospital, Boston, MA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3371/CSRP.6.3.3DOI Listing
October 2012

Religious coping and quality of life among individuals living with schizophrenia.

Psychiatr Serv 2012 Oct;63(10):1051-4

Social Science Research Institute, P.O. Box 93412, Bryan Center, Duke University, Durham, NC 27708, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1176/appi.ps.201000208DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3760767PMC
October 2012

Substance use and schizophrenia: adverse correlates in the CATIE study sample.

Schizophr Res 2011 Nov 26;132(2-3):177-82. Epub 2011 Aug 26.

Department of Psychiatry, Yale University School of Medicine, 333 Cedar Street, New Haven, CT 06510, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.schres.2011.07.032DOI Listing
November 2011

Longitudinal consent-related abilities among research participants with schizophrenia: results from the CATIE study.

Schizophr Res 2011 Aug 10;130(1-3):47-52. Epub 2011 May 10.

Department of Psychiatry, Columbia University College of Physicians and Surgeons, 1051 Riverside Drive, New York, NY 10032, United States.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.schres.2011.04.012DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3139717PMC
August 2011

Effectiveness of switching from antipsychotic polypharmacy to monotherapy.

Am J Psychiatry 2011 Jul 2;168(7):702-8. Epub 2011 May 2.

New York State Psychiatric Institute, New York, NY 10032, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1176/appi.ajp.2011.10060908DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3739691PMC
July 2011

Review: clozapine shows some improved clinical efficacy over risperidone and zotepine in treatment of schizophrenia, but robust evidence is lacking.

Evid Based Ment Health 2011 May;14(2):53

Department of Psychiatry and Behavioral Sciences, Duke University Medical Center, Durham, North Carolina, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/ebmh.14.2.53DOI Listing
May 2011

Treatment outcomes of patients with tardive dyskinesia and chronic schizophrenia.

J Clin Psychiatry 2011 Mar 10;72(3):295-303. Epub 2010 Aug 10.

Department of Psychiatry, Veterans Affairs Medical Center and University of Pennsylvania School of Medicine, Philadelphia, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4088/JCP.09m05793yelDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3825701PMC
March 2011

Genome-wide pharmacogenomic study of neurocognition as an indicator of antipsychotic treatment response in schizophrenia.

Neuropsychopharmacology 2011 Feb 24;36(3):616-26. Epub 2010 Nov 24.

Center for Biomarker Research and Personalized Medicine, School of Pharmacy, Medical College of Virginia Campus, Virginia Commonwealth University, Richmond, VA 23298-0533, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/npp.2010.193DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3055694PMC
February 2011

First- and second-generation antipsychotics.

Can J Psychiatry 2010 Mar;55(3):144-8; discussion 148-9

Duke University Medical Center, Juh Clinical Research, Butner, North Carolina 27509, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/070674371005500305DOI Listing
March 2010

Pharmacogenetics of antipsychotic response in the CATIE trial: a candidate gene analysis.

Eur J Hum Genet 2009 Jul 21;17(7):946-57. Epub 2009 Jan 21.

Center for Human Genome Variation, Institute for Genome Sciences & Policy, Duke University, Durham, NC 27708, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/ejhg.2008.264DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2986499PMC
July 2009

Metabolic profiles of second-generation antipsychotics in early psychosis: findings from the CAFE study.

Schizophr Res 2009 Jun 26;111(1-3):9-16. Epub 2009 Apr 26.

Department of Psychiatry, University of Massachusetts Medical School, Worcester, MA 01605, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.schres.2009.03.025DOI Listing
June 2009

Much ado about small differences.

Authors:
Joseph P McEvoy

World Psychiatry 2009 Feb;8(1):29-30

Duke University Medical Center, Durham, NC, USA.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2645009PMC
February 2009

Results of phase 3 of the CATIE schizophrenia trial.

Schizophr Res 2009 Jan 21;107(1):1-12. Epub 2008 Nov 21.

Department of Psychiatry, School of Medicine, University of North Carolina at Chapel Hill, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.schres.2008.10.011DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2675163PMC
January 2009

Antipsychotic effects on estimated 10-year coronary heart disease risk in the CATIE schizophrenia study.

Schizophr Res 2008 Oct 4;105(1-3):175-87. Epub 2008 Sep 4.

Johns Hopkins Medical Institutions, Welch Center for Prevention, Epidemiology and Clinical Research, 2024 East Monument Street, Suite 2-500, Baltimore, MD 21287, United States.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.schres.2008.07.006DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2614656PMC
October 2008

Functional outcomes in schizophrenia.

Authors:
Joseph P McEvoy

J Clin Psychiatry 2008 ;69 Suppl 3:20-4

Duke University Medical Center, Durham, NC, USA.

View Article

Download full-text PDF

Source
July 2008

Comparison of antipsychotic medication effects on reducing violence in people with schizophrenia.

Br J Psychiatry 2008 Jul;193(1):37-43

Department of Psychiatry and Behavioral Sciences, Duke University School of Medicine, 905 West Main Street, Durham, NC 27710, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1192/bjp.bp.107.042630DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2801826PMC
July 2008

What CATIE found: results from the schizophrenia trial.

Psychiatr Serv 2008 May;59(5):500-6

Department of Psychiatry and Behavioral Sciences, Duke University School of Medicine, Durham, NC 27710, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1176/ps.2008.59.5.500DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5033643PMC
May 2008

The costs of schizophrenia.

Authors:
Joseph P McEvoy

J Clin Psychiatry 2007 ;68 Suppl 14:4-7

Department of Clinical Research, Duke University, Butner, NC 27509, USA.

View Article

Download full-text PDF

Source
April 2008

The effectiveness of antipsychotic medications in patients who use or avoid illicit substances: results from the CATIE study.

Schizophr Res 2008 Mar 11;100(1-3):39-52. Epub 2008 Jan 11.

Department of Psychiatry and Behavioral Sciences, Duke University Medical Center, Durham NC 27710, United States.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.schres.2007.11.034DOI Listing
March 2008

Determining when impairment constitutes incapacity for informed consent in schizophrenia research.

Br J Psychiatry 2007 Jul;191:38-43

Department of Psychiatry, Bioethics Program, and Center for Behavioral and Decision Sciences in Medicine, University of Michigan, 300 North Ingalls, Ann Arbor, MI 48109-0429, and Massachusetts General Hospital, Boston, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1192/bjp.bp.106.033324DOI Listing
July 2007

Effects of olanzapine, quetiapine, and risperidone on neurocognitive function in early psychosis: a randomized, double-blind 52-week comparison.

Am J Psychiatry 2007 Jul;164(7):1061-71

Department of Psychiatry and Behavioral Sciences, Duke University Medical Center, Durham, NC 27710, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1176/ajp.2007.164.7.1061DOI Listing
July 2007

The importance of early treatment of schizophrenia.

Authors:
Joseph P McEvoy

Behav Healthc 2007 Apr;27(4):40-3

Duke University Medical Center, North Carolina, USA.

View Article

Download full-text PDF

Source
April 2007

Catatonic coma with profound bradycardia.

Psychosomatics 2007 Jan-Feb;48(1):74-8

Department of Psychiatry, Massachusetts General Hospital, Boston, MA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1176/appi.psy.48.1.74DOI Listing
February 2007

Insight in first-episode psychosis.

Psychol Med 2006 Oct 2;36(10):1385-93. Epub 2006 Jun 2.

John Umstead Hospital, Duke University Department of Psychiatry, Butner, NC 27509, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1017/S0033291706007793DOI Listing
October 2006

Interrelationships of psychiatric symptom severity, medical comorbidity, and functioning in schizophrenia.

Psychiatr Serv 2006 Aug;57(8):1102-9

Department of Psychiatry, Yale University School of Medicine, New Haven, CT 06519, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1176/ps.2006.57.8.1102DOI Listing
August 2006

Substance use and psychosocial functioning in schizophrenia among new enrollees in the NIMH CATIE study.

Psychiatr Serv 2006 Aug;57(8):1110-6

Department of Psychiatry and Behavioral Sciences, Duke University Medical Center, Durham, NC 27710, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1176/ps.2006.57.8.1110DOI Listing
August 2006

An overview of the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) study.

Authors:
Joseph P McEvoy

CNS Spectr 2006 Jul;11(7 Suppl 7):4-8

Department of Psychiatry, Duke University Medical Center, Durham, NC 27509, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1017/s1092852900026626DOI Listing
July 2006

Risks versus benefits of different types of long-acting injectable antipsychotics.

Authors:
Joseph P McEvoy

J Clin Psychiatry 2006 ;67 Suppl 5:15-8

John Umstead Hospital, 1003 12th Street, Butner, NC 27509, USA.

View Article

Download full-text PDF

Source
July 2006

A national study of violent behavior in persons with schizophrenia.

Arch Gen Psychiatry 2006 May;63(5):490-9

Department of Psychiatry and Behavioral Sciences, Duke University Medical Center, Durham, NC 27710, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/archpsyc.63.5.490DOI Listing
May 2006

Predictors of antipsychotic medication adherence in patients recovering from a first psychotic episode.

Schizophr Res 2006 Mar 9;83(1):53-63. Epub 2006 Mar 9.

Department of Psychiatry, C.B.# 7160, University of North Carolina School of Medicine, Chapel Hill, 27599-7160, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.schres.2005.10.016DOI Listing
March 2006

Striatal dopamine D2/D3 receptor availability in male smokers.

Psychiatry Res 2006 Jan 15;146(1):87-90. Epub 2005 Dec 15.

Department of Psychiatry, College of Medicine, National Cheng Kung University, 138, Sheng Li Road, Tainan 704, Taiwan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.pscychresns.2005.09.008DOI Listing
January 2006

Clinical correlates of tardive dyskinesia in schizophrenia: baseline data from the CATIE schizophrenia trial.

Schizophr Res 2005 Dec 19;80(1):33-43. Epub 2005 Sep 19.

University of Iowa Carver College of Medicine, Psychiatry Research, #2-105 MEB, 500 Newton Rd., Iowa City, IA 52242 1000, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.schres.2005.07.034DOI Listing
December 2005

A comparison of ten-year cardiac risk estimates in schizophrenia patients from the CATIE study and matched controls.

Schizophr Res 2005 Dec 28;80(1):45-53. Epub 2005 Sep 28.

Massachusetts General Hospital, Harvard Medical School, Department of Psychiatry 25 Staniford Street, Boston, MA 02114, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.schres.2005.08.010DOI Listing
December 2005

Course and predictors of weight gain in people with first-episode psychosis treated with olanzapine or haloperidol.

Br J Psychiatry 2005 Dec;187:537-43

Schizophrenia Programme,Centre for Addiction and Mental Health, 250 College Street, Toronto, Ontario, Canada M5T 1R8.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1192/bjp.187.6.537DOI Listing
December 2005

Effectiveness of antipsychotic drugs in patients with chronic schizophrenia.

N Engl J Med 2005 Sep 19;353(12):1209-23. Epub 2005 Sep 19.

Department of Psychiatry, College of Physicians and Surgeons, Columbia University, New York State Psychiatric Institute, New York, NY 10032, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa051688DOI Listing
September 2005

The SNAP-25 gene may be associated with clinical response and weight gain in antipsychotic treatment of schizophrenia.

Neurosci Lett 2005 May 26;379(2):81-9. Epub 2005 Jan 26.

Neurogenetics Section, Centre for Addiction and Mental Health, Department of Psychiatry, University of Toronto, 250 College Street R30, Toronto, Ont. M5T 1R8, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.neulet.2004.12.037DOI Listing
May 2005

Aripiprazole: pharmacology, efficacy, safety and tolerability.

Expert Rev Neurother 2005 May;5(3):297-307

Duke University Medical Center, Department of Psychiatry and Behavioral Sciences, Durham, NC 27710, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1586/14737175.5.3.297DOI Listing
May 2005

Identification of a naturally occurring 21 bp deletion in alpha 2c noradrenergic receptor gene and cognitive correlates to antipsychotic treatment.

Pharmacol Res 2005 Apr;51(4):381-4

Neurogenetics Section, Centre for Addiction and Mental Health, Department of Psychiatry, University of Toronto, 250 College Street R-30, Toronto, Ont., Canada M5T 1R8.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.phrs.2004.10.013DOI Listing
April 2005

Long-acting risperidone vs. placebo in the treatment of hospital inpatients with schizophrenia.

Schizophr Res 2005 Jan;72(2-3):249-58

Department of Psychiatry MSC095030, 1 University of New Mexico Health Sciences Center, Albuquerque, NM 87131-001, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.schres.2004.05.006DOI Listing
January 2005

Revised PORT recommendations.

Schizophr Bull 2004 ;30(3):609-11

University of North Carolina at Chapel Hill, 10626 Neurosciences Hospital, Campus Box #7160, Chapel Hill, NC 27599-7160, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/oxfordjournals.schbul.a007106DOI Listing
January 2005